Search

everythinglearnresearchcommunity

for

Search:↓

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

Drugmakers are optimistic about targeting the Wnt pathway for new treatments despite past challenges.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

Cancer treatments can cause skin-related side effects that may affect patient quality of life and require changes in treatment.

Scalp cooling is the most effective FDA-approved method to prevent chemotherapy-induced hair loss, but more research is needed for other treatments.

Alopecia areata is an autoimmune disease causing patchy hair loss, often with other autoimmune disorders, but its exact causes are unknown.

The document concludes that while there are promising methods to control CRISPR/Cas9 gene editing, more research is needed to overcome challenges related to safety and effectiveness for clinical use.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Autophagy helps keep skin healthy and may improve treatments for skin diseases.

Targeted anticancer therapies can cause severe side effects similar to traditional chemotherapy, but with different types.

Four specific genes are linked to keloid formation and could be potential treatment targets.

Intestinal intraepithelial lymphocytes are crucial for gut immunity and maintaining the mucosal barrier.

Immunotherapy for cancer caused a patient to develop a condition affecting hormone production, requiring ongoing hormone replacement therapy.

Higher PD-1 levels are linked to fewer immune cells in hair follicles in alopecia areata.

Topical JAK inhibitors may help treat some skin conditions but need more research.

Gray hair can potentially be reversed, leading to new treatments.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.

Pantethine may boost the immune system's ability to fight sarcoma.

Stopping mitochondrial respiration can prevent brain cancer spread in skin cancer patients, and plant compound β-sitosterol could help achieve this.

The document explains how the immune system reacts to organ transplants and the treatments used to prevent rejection.

The research confirms that Hidradenitis Suppurativa is characterized by increased inflammation, disrupted skin cell organization, and abnormal metabolic processes.

Melanoma's complexity requires personalized treatments due to key genetic mutations and tumor-initiating cells.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

The document concludes that computational models are useful for understanding immune responses and could improve cancer immunotherapy.

Contact immunotherapy might help treat various skin conditions, but more research is needed to confirm its safety and effectiveness.

The document concludes that more research is needed to reduce frequent hospital visits, addiction medicine education improves with specific training, early breast cancer surgery findings are emerging, nipple smears are not very accurate, surgery for older melanoma patients doesn't extend life, a genetic condition in infants can often be treated with one drug, doctors are inconsistent with blood clot medication, a certain gene may protect against cell damage, muscle gene overexpression affects many other genes, and some mitochondrial genes are less active in mice with tumors.

New compounds were made that effectively block enzymes related to prostate issues and hair loss.

Changing the C-ring structure in certain compounds can make them better at blocking a specific human enzyme.

Compound 4 is a promising treatment for hair loss with low toxicity.